"I need to increase my market share, despite my maturing portfolio."
As governments squeeze costs and competition mounts in maturing markets, growth is moving elsewhere.
But even though the emerging markets offer unlimited scope for expansion, they’re dominated by generics, and might not have the budgets or government will to fund your branded products.
Our expertise and in-depth market knowledge can help you manage your patent portfolio more effectively, ensuring all your application and renewal dates are known and met and maximizing your protection against potential generic competition.
By identifying new uses for your existing patents to cover new indications and formulations, you can extend your product’s life. Our SWOT analysis can pinpoint the global strengths and weaknesses of your product against its competitors.
We’ll help fashion your data into concise, industry-standard formats that communicate the essential information to your target audience quickly, accurately, and in the language they expect. All our writers are medical specialists skilled in all aspects of preparing and executing successful and relevant communication programs.
With Thomson Reuters guiding your business development decisions, you'll make your company a more attractive proposition to investors.
Hot off the Press
Subscribe to our latest white paper, Key Opinion Leader Identification and Selection, to receive your complimentary copy.
Essential Solutions
Who can benefit
- Competitive intelligence professionals
- Intellectual property professionals
- Licensing and business development
- Regulatory affairs managers
- Brand managers/marketing